Leroux 1.5 Gm Inj

Cefuroxime Axetil + Potassium Clavulanate

• A second generation cephalosporin, highly resistant to destruction by Beta-lactamases produced by Staphylococci & most of gram-negative bacteria.
•  First line treatment option due to its excellent efficacy, safety & tolerability profile.
•  Rapidly penetrates into body tissues and fluids.
• Shows extended half life which allows longer dosing interval and reduction in total drug cost.
• Effectively reduces incidence of post operative infections in patients undergoing surgical procedure.
•  A very safe drug without causing nephrotoxicity in comparison to other cephalosporins.
• Produces more rapid bacterial response & well tolerated as compared with cephalothin.
• Provides good efficacy and better safety profile in treatment of acute bronchitis as compared to amoxicillin clavulanic acid.
• Superior in both terms of clinical efficacy and global utility
  
  

Indication:

• Acute & chronic bronchitis
• Otitis media
• Pharyngitis
• Bone & joint infections
• Septicemia
• Soft Tissue infections
•  Meningitis
• Tonsillitis
•  UTI